LETTER TO THE EDITOR
Mitral Transcatheter Edge-to-Edge Repair (MTEER) in Heart Failure Patients Refractory to Cardiac Resynchronization Therapy
Farah Yasmin,
Asim Shaikh,
Eman Ali, Hala Najeeb, Zunera Huda, Unaiza Naeem, Safi Khan,
Sachin S. Goel,
Corresponding Author
Farah Yasmin
Yale School of Medicine, New Haven, Connecticut, USA
Correspondence: Farah Yasmin ([email protected])
Search for more papers by this authorAsim Shaikh
Houston Methodist DeBakey Heart & Vascular Center, Texas, USA
Search for more papers by this authorSafi Khan
Houston Methodist DeBakey Heart & Vascular Center, Texas, USA
Search for more papers by this authorSachin S. Goel
Houston Methodist DeBakey Heart & Vascular Center, Texas, USA
Search for more papers by this authorFarah Yasmin,
Asim Shaikh,
Eman Ali, Hala Najeeb, Zunera Huda, Unaiza Naeem, Safi Khan,
Sachin S. Goel,
Corresponding Author
Farah Yasmin
Yale School of Medicine, New Haven, Connecticut, USA
Correspondence: Farah Yasmin ([email protected])
Search for more papers by this authorAsim Shaikh
Houston Methodist DeBakey Heart & Vascular Center, Texas, USA
Search for more papers by this authorSafi Khan
Houston Methodist DeBakey Heart & Vascular Center, Texas, USA
Search for more papers by this authorSachin S. Goel
Houston Methodist DeBakey Heart & Vascular Center, Texas, USA
Search for more papers by this authorFirst published: 01 April 2025
Supporting Information
| Filename | Description |
|---|---|
| ccd31518-sup-0001-Final_Supplementary_doc.docx11.3 MB | Final Supplementary doc.docx. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1T. M. Koelling, K. D. Aaronson, R. J. Cody, D. S. Bach, and W. F. Armstrong, “Prognostic Significance of Mitral Regurgitation and Tricuspid Regurgitation in Patients With Left Ventricular Systolic Dysfunction,” American Heart Journal 144, no. 3 (2002): 524–529.
- 2B. H. Trichon, G. M. Felker, L. K. Shaw, C. H. Cabell, and C. M. O'Connor, “Relation of Frequency and Severity of Mitral Regurgitation to Survival Among Patients With Left Ventricular Systolic Dysfunction and Heart Failure,” American Journal of Cardiology 91, no. 5 (2003): 538–543.
- 3M. Mirabel, B. Iung, G. Baron, et al., “What Are the Characteristics of Patients With Severe, Symptomatic, Mitral Regurgitation Who Are Denied Surgery?,” European Heart Journal 28, no. 11 (2007): 1358–1365.
- 4A. H. Wu, K. D. Aaronson, S. F. Bolling, F. D. Pagani, K. Welch, and T. M. Koelling, “Impact of Mitral Valve Annuloplasty on Mortality Risk in Patients With Mitral Regurgitation and Left Ventricular Systolic Dysfunction,” Journal of the American College of Cardiology 45, no. 3 (2005): 381–387.
- 5L. Di Biase, A. Auricchio, P. Mohanty, et al., “Impact of Cardiac Resynchronization Therapy on the Severity of Mitral Regurgitation,” Europace: European pAcing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 13, no. 6 (2011): 829–838.
- 6K. Dickstein, P. E. Vardas, A. Auricchio, et al., “2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure: An Update of the 2008 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure and the 2007 ESC Guidelines for Cardiac and Resynchronization Therapy. Developed With the Special Contribution of the Heart Failure Association and the European Heart Rhythm Association,” European Heart Journal 31, no. 21 (2010): 2677–2687.
- 7C. Ypenburg, R. J. van Bommel, C. J. W. Borleffs, et al., “Long-Term Prognosis After Cardiac Resynchronization Therapy Is Related to the Extent of Left Ventricular Reverse Remodeling at Midterm Follow-Up,” Journal of the American College of Cardiology 53, no. 6 (2009): 483–490.
- 8T. Onishi, T. Onishi, J. J. Marek, et al., “Mechanistic Features Associated With Improvement in Mitral Regurgitation After Cardiac Resynchronization Therapy and Their Relation to Long-Term Patient Outcome,” Circulation: Heart Failure 6, no. 4 (2013): 685–693.
- 9T. Feldman, H. S. Wasserman, H. C. Herrmann, et al., “Percutaneous Mitral Valve Repair Using the Edge-to-Edge Technique,” Journal of the American College of Cardiology 46, no. 11 (2005): 2134–2140.
- 10T. Feldman, S. Kar, M. Rinaldi, et al., “Percutaneous Mitral Repair With the Mitraclip System,” Journal of the American College of Cardiology 54, no. 8 (2009): 686–694.
- 11G. W. Stone, J. Lindenfeld, W. T. Abraham, et al., “Transcatheter Mitral-Valve Repair in Patients With Heart Failure,” New England Journal of Medicine 379, no. 24 (December 2018): 2307–2318, https://doi.org/10.1056/NEJMoa1806640.
- 12S. D. Anker, T. Friede, R. S. von Bardeleben, et al. RESHAPE-HF2 Investigators., “Transcatheter Valve Repair in Heart Failure With Moderate to Severe Mitral Regurgitation,” New England Journal of Medicine 391 (August 2024): 1799–1809, https://doi.org/10.1056/NEJMoa2314328.
- 13H. Jneid, J. Chikwe, S. V. Arnold, et al., “2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures,” Circulation: Cardiovascular Quality and Outcomes 17, no. 4 (April 2024): e000129, https://doi.org/10.1161/HCQ.0000000000000129.
- 14G. A. Wells BS, D. O'Connell, J. Peterson, V. Welch, M. Losos, and P. Tugwelld, The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Our Research, https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp#:~:text=The%20Newcastle%2DOttawa%20Scale%20(NOS,challenging%20to%20implement%20and%20conduct.
- 15J. A. C. Sterne, J. Savović, M. J. Page, et al., “RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials,” BMJ 366 (2019): l4898.
- 16A. Berardini, E. Biagini, F. Saia, et al., “Percutaneous Mitral Valve Repair: The Last Chance for Symptoms Improvement in Advanced Refractory Chronic Heart Failure?,” International Journal of Cardiology 228 (2017): 191–197.
- 17G. D'Ancona, H. Ince, W. Schillinger, et al., “Percutaneous Treatment of Mitral Regurgitation in Patients With Impaired Ventricular Function: Impact of Intracardiac Electronic Devices (From the German Transcatheter Mitral Valve Interventions Registry),” Catheterization and Cardiovascular Interventions 94, no. 5 (2019): 755–763.
- 18A. Auricchio, W. Schillinger, S. Meyer, et al., “Correction of Mitral Regurgitation in Nonresponders to Cardiac Resynchronization Therapy by Mitraclip Improves Symptoms and Promotes Reverse Remodeling,” Journal of the American College of Cardiology 58, no. 21 (2011): 2183–2189.
- 19I. Kosmidou, J. Lindenfeld, W. T. Abraham, et al., “Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial,” Circulation: Heart Failure 13, no. 11 (2020): e007293.
- 20V. L. Giaimo, P. Zappulla, A. Cirasa, et al., “Long-Term Clinical and Echocardiographic Outcomes of Mitraclip Therapy in Patients Nonresponders to Cardiac Resynchronization,” Pacing and Clinical Electrophysiology 41, no. 1 (2018): 65–72.
- 21M. Seifert, T. Schau, M. Schoepp, A. Arya, M. Neuss, and C. Butter, “Mitraclip in CRT Non-Responders With Severe Mitral Regurgitation,” International Journal of Cardiology 177, no. 1 (2014): 79–85.
- 22X. Freixa, J. M. Tolosana, P. L. Cepas-Guillen, et al., “Edge-To-Edge Transcatheter Mitral Valve Repair Versus Optimal Medical Treatment in Nonresponders to Cardiac Resynchronization Therapy: The Mitra-CRT Trial,” Circulation. Heart failure 15, no. 12 (2022): 009501, https://doi.org/10.1161/circheartfailure.121.009501.
- 23S. S. Natanzon, A. Shechter, R. J. Siegel, et al., “Outcomes of Transcatheter Edge-To-Edge Repair for Functional Mitral Regurgitation According to Cardiac Resynchronization Therapy Status,” American Journal of Cardiology 203 (2023): 265–273, https://doi.org/10.1016/j.amjcard.2023.07.016.
- 24C. Giannini, F. D'ascenzo, F. Fiorelli, et al., “A Meta-Analysis of Mitraclip Combined With Medical Therapy Vs. Medical Therapy Alone for Treatment of Mitral Regurgitation in Heart Failure Patients,” ESC Heart Failure 5, no. 6 (2018): 1150–1158.
- 25A. Vallakati, A. K. Hasan, and K. D. Boudoulas, “Transcatheter Mitral Valve Repair in Patients With Heart Failure: A Meta-Analysis,” Cardiology 146, no. 1 (2021): 42–48.
- 26S. Goel, R. T. Pasam, K. Wats, et al., “Mitraclip Plus Medical Therapy Versus Medical Therapy Alone for Functional Mitral Regurgitation: A Meta-Analysis,” Cardiology and Therapy 9, no. 1 (2020): 5–17.
- 27D. D. Glower, S. Kar, A. Trento, et al., “Percutaneous Mitral Valve Repair for Mitral Regurgitation in High-Risk Patients,” Journal of the American College of Cardiology 64, no. 2 (2014): 172–181.
- 28S. M. Pio, D. Medvedofsky, V. Delgado, et al., “Left Atrial Improvement in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial,” JACC: Cardiovascular Imaging 17, no. 9 (2024): 1015–1027.
- 29G. W. Stone, J. Lindenfeld, W. T. Abraham, et al., “Transcatheter Mitral-Valve Repair in Patients With Heart Failure,” New England Journal of Medicine 379, no. 24 (2018): 2307–2318.
- 30N. A. Geis, M. Puls, E. Lubos, et al., “Safety and Efficacy of Mitraclip Therapy In Patients With Severely Impaired Left Ventricular Ejection Fraction: Results From the German Transcatheter Mitral Valve Interventions (Trami) Registry,” European Journal of Heart Failure 20, no. 3 (2018): 598–608.
- 31F. Maisano, O. Franzen, S. Baldus, et al., “Percutaneous Mitral Valve Interventions in the Real World,” Journal of the American College of Cardiology 62, no. 12 (2013): 1052–1061.
- 32S. Baldus, W. Schillinger, O. Franzen, et al., “MitraClip Therapy in Daily Clinical Practice: Initial Results From the German Transcatheter Mitral Valve Interventions (TRAMI) Registry,” European Journal of Heart Failure 14, no. 9 (2012): 1050–1055.
- 33M. Paukovitsch, N. Schepperle, A. Pott, et al., “Impact of Bleeding Complications After Transcatheter Mitral Valve Repair,” IJC Heart & Vasculature 32 (2021): 100707.
